Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Qliro Group has carried out a directed share issue of approximately SEK 210 million – the Board of Directors proposes a distribution of the shares in Qliro AB to the shareholders of Qliro Group

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR OTHER MEASURESPress release, Stockholm, 26 August 2020 Qliro Group AB (publ) (“Qliro Group” or the “Company”) (Nasdaq Stockholm: QLRO) hereby announces that the Company has carried out a directed share issue of approximately 30 million new ordinary shares, at a subscription price of SEK 7.00 per share (the “New

K-Fast Holding completes a directed new share issue of 2,000,000 B-shares, raising SEK 504 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESK-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has in accordance with the Company’s press release earlier today on 26 of August 2020 and based on the authorisation granted by the annual general meeting on 19 May 2020, resolved on

­Sale of shares in Hansa Biopharma AB (publ)

Press release Stockholm 26 August 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Nexttobe AB (“Nexttobe”) has sold 3.6 million shares in Hansa Biopharma AB (publ) ("Hansa Biopharma") through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 240 per share (the “Share Sale”). Following the Share Sale, Nexttobe owns 2,155,379 shares in Hansa Biopharma, corresponding

The EU Commission grants conditional approval for Idefirix[TM] (imlifidase) in highly sensitized kidney transplant patients in the European Union

The conditional approval by the European Commission serves as a landmark milestone for Hansa Biopharma, as Idefirix[TM] (imlifidase) will be the Company’s first approved drug and will transform Hansa Biopharma into a commercial stage biopharmaceutical companyLund, Sweden August 26, 2020. Hansa Biopharma (“Hansa”), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the European Commission has granted conditional approval for IdefirixTM in highly sensitized kidney transplants patients. The formal approval by the European Commission was

Heimstaden Bostad successfully places EUR 650m senior unsecured bond

Heimstaden Bostad AB has today successfully completed the issue of a EUR 650 million senior unsecured bond under its EMTN programme. The bond has a maturity of 6.5 years and carries a fixed coupon of 1.375% p.a. The company intends to allocate a share of the proceeds for the repayment of short-term bank loans. Proceeds will also be used to finance the ongoing tender offer to buy back up to EUR 150 million of its outstanding EUR 500 million senior unsecured bond maturing in December 2021. All remaining proceeds will be used for general corporate purposes. Commenting on the transaction,

Nustay A/S: Publication of Half-Year Report for 2020

Nustay A/S (“Nustay”) hereby publishes its Half-Year Report for the period January – June 2020. The report is available as an attached document to this press release and on the company's website (investor.nustay.com). Below is a summary of the report.CEO Mathias Lundoe Nielsen comments: “The first half of 2020 has without a doubt been one of the toughest and most challenging periods for Nustay yet. With prolonged lockdown and travel bans, the travel industry has been one of the industries most affected by the COVID-crisis. Despite this, we have been able to further expand our product

WorkWave CEO David F. Giannetto Named a Top 50 SaaS CEO

Giannetto recognized for forward-looking approach to SaaS software leadershipHolmdel, NJ - August 26, 2020 - WorkWave [®], a provider of cloud-based software solutions that support every stage of a service business’s lifecycle, today announces that its CEO, David F. Giannetto, has been named a Top 50 SaaS CEO  by The Software Report, a comprehensive source for market research and insights, business news, investment activity and corporate actions related to the software sector. The Top 50 SaaS CEOs of

Correction: The directed new share issue comprises approximately 2 million shares

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESReferral to press release issued at 5.45 on 26 August 2020. K-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has mandated Danske Bank (The “Bookrunner”) to evaluate the conditions for carrying out a directed new share issue of

DreamHack Open Fall European RMR to Begin October 15 – Event to Offer Prize Pool Totaling $115,000

Roster Lock for All Teams in RMR, Sept. 9; Open Qualifiers, Sept. 18-20; Closed Qualifiers, Sept. 22-25; Main Event, Oct. 15-25STOCKHOLM — The DreamHack Open Fall  European Regional Major Rankings (RMR) Tournament will take place October 15-25, with a prize pool totaling $115,000.   The  all-online competition  will be a version of DreamHack’s popular Counter-Strike: Global Offensive (CS:GO) tournament. The tournament will award RMR points towards the next Valve Major.

ZUTEC REPAYS EUR1M LOAN FROM ATHANASE

Zutec Holding AB (publ) (“Zutec") today announced that it has repaid in full the loan from Athanase of EUR1m plus applicable interest. “In accordance with our intentions at the time of the rights issue we have repaid all the debt to Athanase. We believe that based on the stage of Zutec’s development that being debt free is the appropriate capital structure. We now have a strong cash position and our capital structure has been aligned and our focus is to build on the strong momentum of growth we are experiencing by making further investments into sales and marketing allowing us to

K-Fast Holding evaluates the conditions to carry out a directed new share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURESK-Fast Holding AB (publ) (ticker: KFAST B) (“K-Fast Holding” or the “Company”) has mandated Danske Bank (The “Bookrunner”) to evaluate the conditions for carrying out a directed new share issue of approximately SEK 2 million, through an accelerated bookbuilding

Nexttobe announces its intention to sell shares in Hansa Biopharma AB (publ)

Press release Stockholm 26 August 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Carnegie Investment Bank AB (“Carnegie”) has been retained to explore the opportunity to sell approximately 3.6 million shares, corresponding to approximately 7.8% of total shares and 8.1% of total votes outstanding in Hansa Biopharma AB (“Hansa Biopharma”) to Swedish and international institutional

#20-298 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-297 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 30 500 treasury shares on 26 August 2020. The shares were purchased at an average price of price of NOK 53.2097. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 546 892 treasury shares.  Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no   Selvaag Bolig ASA is a residential property developer which controls the entire value chain from acquisition of land to sale of turnkey homes. The company has several thousand

BAKKAFROST: Purchase of own shares to be used as treasury shares for the Share Savings plan

Today 26 August 2020 Bakkafrost has purchased 25,492 Bakkafrost shares to be used as treasury shares for the Share Savings Plan for employees. The shares were purchased in the market at a price of NOK 542.46 per share. After the share purchase and settlement Bakkafrost holds 53,720 treasury shares. For further information about Bakkafrost's share savings plan, see www.bakkafrost.com/en/investor-relations/share-information/share-savings-plan Contacts: · Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) · Høgni Dahl Jakobsen, CFO of P/F Bakkafrost: +298 23 50 60 (

Mehiläinen Yhtiöt Oy supplements the tender offer document dated 8 January 2020 regarding the public cash tender offer for all shares in Pihlajalinna Plc

THIS STOCK EXCHANGE RELEASE MAY NOT BE RELEASED, PUBLISHED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, NEW ZEALAND, OR SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. Mehiläinen Yhtiöt Oy supplements the tender offer document dated 8 January 2020 regarding the public cash tender offer for all shares in

Embracer Group publishes Annual Report 2019/2020

Embracer Group today publishes its Annual Report for the financial year 2019/2020. The Annual Report is enclosed this press release and also available at the company’s website: https://embracer.com/investors/reports-presentations/If you require a printed version, please contact ir@embracer.com For more information, please contact: Lars Wingefors, Founder and Group CEO, Embracer Group Tel: +46 708 47 19 78 E-mail: lars.wingefors@embracer.com About Embracer Group Embracer Group is the parent company of businesses developing and publishing PC, console and mobile games for the

We are looking for a modern HR person with a growth-driven and future-oriented mindset for the role of Chief People Officer

The future is being created today. At Kiilto, we invest in the future every day by promoting occupational wellbeing, encouraging innovation and making our operations more and more sustainable. We are guided by the desire to be an environmental leader, using our expertise to create success stories for our customers. We are local, innovative and insightful. Would you like to add your own chapter to our hundred-year story of growth?   As our current CPO is leaving for another position outside the Group, we are looking for a modern HR person with a growth-driven and future-oriented

Lars Granlöf appointed new CFO of Bonava

Lars Granlöf has been appointed new CFO of Bonava and will replace Ann-Sofi Danielsson, who has decided to retire.Bonava has appointed Lars Granlöf as new CFO and member of Bonava’s Executive Management, and he will assume the position not later than 1 January 2021. Lars has an M.Sc. in Economics and Business from the Stockholm School of Economics and his latest position was as CFO at Coop Sverige AB, a position he has held since 2015. Prior to this, he held various CFO roles in companies including Saab AB and Gambro AB. “I am very pleased to welcome Lars to Bonava. His solid and

Vestas secures 86 MW order to extend wind project in Finland

News release from Vestas Northern and Central EuropeHamburg, 26 August 2020Vestas has secured an 86 MW order with German developer CPC Germania for the Lakiakangas III project located in Isojoki in the South Ostrobothnia region of Finland. The order includes the supply, installation and commissioning of 20 V150-4.2 MW wind turbines in 4.3 MW Power Optimised Mode as well as a 20-year Active Output Management 5000 (AOM 5000) service agreement that will ensure optimised performance and long-term business case certainty for the customer. Vestas has worked closely with CPC Germania to

Nomination committee appointed ahead of 2021 Annual General Meeting of Cloetta AB (publ)

In accordance with the decision of the Annual General Meeting, Cloetta’s nomination committee shall consist of at least four and at most six members. Cloetta hereby announces that the nomination committee now has been appointed ahead of the Annual General Meeting in April 2021.The nomination committee consists of the following members:Lars Schedin, Chairman, appointed by AB Malfors PromotorStefan Johansson, appointed by PRI PensionsgarantiJohan Törnqvist, appointed by Ulla HåkansonMikael Norman, appointed by the Board of Cloetta AB Cloetta’s 2021 Annual General Meeting will be

Getinge’s new anesthesia machines, Flow-e and Flow-c, receive 510(k) clearance

US Food & Drug Administration (FDA) clears Getinge’s Flow-e and Flow-c Anesthesia Systems. Getinge extends the family of Flow anesthesia machines with Flow-e and Flow-c, which share the same Flow Family core technology and offers personalized anesthesia delivery for even the most challenging patients, from neonates and pediatric to the morbidly obese. The Flow family   is Getinge’s line up of anesthesia machines conceived to cover the needs of all types of surgeries

Report from the Annual General Meeting 2020 in Elekta

STOCKHOLM, August 26, 2020 – Elekta AB (publ) has held its Annual General Meeting on 26 August 2020. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting was conducted by advance postal vote, without physical attendance. A presentation where the Acting President and CEO describes the past year and addresses questions from shareholders is available on the Company's website, www.elekta.com. A summary of the resolutions taken by the Meeting follows. For complete details concerning all resolutions, please see the Meeting documents that are available on the

There are no items matching the current filter
There are no more items matching the current filter
Back to top